Pharmacist prescriptive authority for smoking cessation medications in the United States

Adams, Alex J.; Hudmon, Karen Suchanek

doi:10.1016/j.japh.2017.12.015

Cited by 37 publications

(25 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study advances earlier research by applying novel outcome measures and long-term follow-up in a large number of pharmacies to demonstrate that brief tobacco cessation interventions are both effective and feasible for implementation in the community pharmacy setting. Improvements in the training of pharmacists over the past 2 decades [35][36][37] and recent legislation 38 further support this expanded role and enable pharmacists to practice at the top of their license by (in some states) prescribing all FDA-approved medications for smoking cessation. Pharmacy technicians also play a key role in the overall process by asking about tobacco use, advising patients to quit, and referring patients who are ready to quit for counseling to be provided by the pharmacist or the tobacco quitline.…”

Section: Resultsmentioning

confidence: 99%

Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline

Hudmon¹,

Corelli²,

Moor³

et al. 2018

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

Brief cessation interventions are feasible in community pharmacies, and the 2 approaches evaluated for engaging pharmacy personnel were similarly effective and collectively led to meaningful increases in the number and proportion of all patients who called the quitline. Involvement of community pharmacy personnel in tobacco cessation presents a significant opportunity to promote quitline services by connecting patients with an effective publicly available resource.

show abstract

Section: Resultsmentioning

confidence: 99%

Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline

Hudmon¹,

Corelli²,

Moor³

et al. 2018

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

show abstract

“…Several US states have passed legislation allowing CPs to provide smoking cessation counseling and issue Food and Drug Administration (FDA)–approved tobacco cessation drug therapy. 34 Smoking cessation rates in patients who receive counseling by a pharmacist are similar to those in patients receiving counseling from other HCPs. 35 Even brief pharmacist-led counseling sessions are associated with long periods of continuous abstinence.…”

Section: Counseling For Smoking Cessationmentioning

confidence: 87%

Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease

Hudd

2020

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

“…A physician does not need to sign off on an agreement between pharmacists and the government agency 19 . New Mexico was one of the first states to permit pharmacists to prescribe under a statewide protocol in 2004 with tobacco cessation medications 26 . In some states, alternate terminology that is more palatable to the broader prescriber community has been used to mitigate political battles at the state level.…”

Section: Autonomous Prescribingmentioning

confidence: 99%

Current status of prescriptive authority by pharmacists in the United States

Sachdev

Kliethermes

Vernon

et al. 2020

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Introduction: While pharmacists in other countries have broad independent prescribing privileges, pharmacists in the United States are making progress. Pharmacist prescriptive authority in the U.S. occurs on a continuum with four identified models: patient-specific collaborative prescribing through collaborative practice agreements (CPAs), population-specific prescribing through CPAs, statewide protocols, and classspecific prescribing. States have implemented pharmacist prescriptive authority across this spectrum. As approximately 90% of Americans reside within two miles of a community pharmacy, prescriptive authority of pharmacists leads to improved public health access points and outcomes.Objective: This paper is intended to provide insight into the current landscape of pharmacist prescriptive authority in the United States through 2019 in order to provide historical context and identify opportunities for state policy considerations. This was done through a review of published literature, national professional association resources, individual state pharmacy practice acts, and state legislation and regulations. Conclusion: Significant variability regarding what medications pharmacists can prescribe exists per state statutes. According to data collected from the National Alliance of State Pharmacy Associations (NASPA), 147 bills related to pharmacist provider status were introduced in 39 states during the 2019 legislative session. The interest in pharmacist prescribing stems from current and future challenges within the U.S. health care system: access to care, cost of care, and the anticipated shortage of physicians. The challenge to standardize prescriptive authority across states presents a unique opportunity for future considerations.K E Y W O R D S collaborative practice, collaborative practice agreement, independent prescribing, pharmacist prescribing, prescriptive authority In 2015, the National Association of Boards of Pharmacy (NABP) TaskForce on Pharmacist Prescriptive Authority recommended the inclusion of language in state pharmacy practice acts regarding initiation of medications by pharmacists. Three features for pharmacist prescribing were specifically mentioned in the report: a diagnosis should either not be needed or be readily determined; a formulary listing or protocol be considered; and communication is essential between the pharmacist, patient, and primary care provider. 1 Some groups, primarily from the medical community, argue that pharmacist autonomous prescribing will result in fragmentation of care for patients. 2 Collaboration

show abstract

Pharmacist prescriptive authority for smoking cessation medications in the United States

Cited by 37 publications

References 18 publications

Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline

Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline

Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease

Current status of prescriptive authority by pharmacists in the United States

Contact Info

Product

Resources

About